Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
Authors:ID Collins, Rebecca R. J. (Author)
ID Florke Gee, Rebecca R. (Author)
ID Tozandehjani, Sima (Author)
ID Bayat, Tara (Author)
ID Hoyos Sanchez, Maria Camila (Author)
ID Solano Gutierrez, Juan Sebastian (Author)
ID Breznik, Barbara (Author)
ID Lee, Anna K. (Author)
ID Fon Tacer, Klementina (Author)
Files:URL URL - Source URL, visit https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-025-02055-3
 
.pdf PDF - Presentation file, download (5,57 MB)
MD5: DEA9F156024CEBD10AA4816873FE4C79
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:Medulloblastoma (MB) is the most malignant childhood brain cancer. Group 3 MB (G3 MB) subtype accounts for about 25% of MB and is associated with the worst outcomes. Herein, we report that more than half of G3 MB tumors express melanoma antigens (MAGEs), which are potential prognostic and therapeutic markers. MAGEs are cancer‑testis antigens, aberrantly expressed in several adult cancers, and associated with poorer prognosis and therapy resistance; however, their role in pediatric cancers is mostly unknown. This study aimed to determine whether MAGEs are activated and important in pediatric MB. We obtained formalin‑fixed paraffin‑embedded tumor samples of 34 patients, collected between 2008 and 2015 at the Children’s Medical Center in Dallas and applied our validated reverse transcription quantitative PCR (RT‑qPCR) assay to measure the expression of 23 MAGE genes. To validate our data, we analyzed published datasets from pediatric MB tumors and patient‑derived orthotopic xenografts, totaling 949 patients. Our RT‑qPCR analysis suggested that MAGEs were expressed in G3/4MB. Further mining of bulk and single‑cell RNA‑sequencing datasets confirmed that 50–75% of G3 tumors activate several MAGEs. Intriguingly, single‑cell data analysis showed that MAGEs are expressed in distinct subsets of cells in MAGE‑positive tumors and are not activated in mouse genetic models, suggesting they contribute to the tumor heterogeneity and species‑specificity of G3 MB. We then examined how MAGE expression affects the growth and oncogenic potential by CRISPR‑Cas9‑ and siRNA‑mediated gene depletion. Depletion of MAGEAs, ‑B2, and ‑Cs altered cell survival, viability, and clonogenic growth due to decreased proliferation and increased apoptosis of MAGE‑positive MB cells. These findings suggested that targeting MAGEs could represent a viable therapeutic strategy for G3 MB. A deeper understanding of MAGE regulation and function is warranted and could aid in improving prognostic and therapeutic approaches for this poorly characterized subgroup of pediatric brain tumors.
Keywords:medulloblastoma, tumor antigens, MAGE, pediatric cancer, cancer‑testis antigens
Publication status:Published
Publication version:Version of Record
Publication date:28.07.2025
Year of publishing:2025
Number of pages:str. 1-16
Numbering:Vol. 13, [article no.] 164
PID:20.500.12556/DiRROS-23650 New window
UDC:577.2
ISSN on article:2051-5960
DOI:10.1186/s40478-025-02055-3 New window
COBISS.SI-ID:244648963 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 1. 8. 2025; Soavtorji: Rebecca R. Florke Gee, Sima Tozandehjani, Tara Bayat, Maria Camila Hoyos Sanchez, Juan Sebastian Solano Gutierrez, Barbara Breznik, Anna K. Lee, Samuel T. Peters, Jon P. Connelly, Shondra M. Pruett-Miller, Martine F. Roussel, Dinesh Rakheja, Heather S. Tillman, Patrick Ryan Potts & Klementina Fon Tacer;
Publication date in DiRROS:19.09.2025
Views:313
Downloads:144
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Acta neuropathologica communications
Shortened title:Acta Neuropathol. Commun.
Publisher:BioMed Central
ISSN:2051-5960
COBISS.SI-ID:522939929 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0245-2019
Name:Ekotoksiologija, toksikološka genomika in karcinogeneza

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4504-2022
Name:Z vizualizacijo mikrookolja glioblastoma do boljše terapije

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:BI-US/22-24-007-2022
Name:Vloga proteinov MAGE v glioblastomskih matičnih celicah in odpornosti na terapijo: ali nam lahko znanje o biologiji matičnih celicah pomaga zdraviti na terapijo odporne možganske tumorje?

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:BI-US/24-26-022-2024
Name:Izkoriščanje proteinov MAGE za boj proti odpornosti agresivnih tumorjev na zdravljenje

Funder:EC - European Commission
Funding programme:HE
Project number:101079113
Name:TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
Acronym:CutCancer

Funder:National Institutes of Health National Cancer Institute
Project number:T32CA136515, CA096832 and CA21765

Funder:American Cancer Society Research Scholar Award
Project number:181691010

Funder:Cancer Prevention and Research Institute of Texas
Project number:R1117, RR200059

Funder:Texas Tech University start-up and the Texas Center for Comparative Cancer Research
Project number:TC3R

Funder:Foundation for Prader–Willi Syndrome Research Grants
Project number:22-0321 and 23-0447

Funder:Fulbright fellowship; John Lawrence and Patsy Louise Goforth Distinguished Chair in Pathology endowment; American Lebanese Syrian Associated Charities of St Jude Children’s Research Hospital

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:meduloblastom, otroški možganski tumorji, MAGE, heterogenost, terapevtske tarče


Back